Home MCQs BS Nursing
C.
Vaccine Efficacy (or Vaccine Effectiveness in real-world).
✓
A.
Wait for the pathogen to be fully characterized.
✓
B.
Initiate rapid risk assessment, develop containment strategies, and prepare for potential outbreak/pandemic.
✓
C.
Dismiss it as a non-issue.
✓
D.
Only focus on research.
✓
C.
Mode of transmission.
✓
C.
Attributable Risk (AR).
✓
D.
Population Attributable Risk (PAR).
✓
A.
Pre-clinical studies.
✓
C.
Post-marketing surveillance (Pharmacovigilance).
✓
D.
Regulatory approval.
✓
B.
Cross-sectional study.
✓
D.
Randomized controlled trial.
✓
A.
Focus on treating individual patients in affected countries.
✓
B.
Initiate rapid global surveillance, develop and disseminate diagnostic tests, and begin vaccine development efforts.
✓
C.
Wait for the pandemic to subside naturally.
✓
D.
Restrict all international travel indefinitely.
✓
C.
Positive Predictive Value.
✓
D.
Negative Predictive Value.
✓
A.
Pre-clinical studies.
✓
A.
Send in medical supplies for symptomatic treatment.
✓
B.
Dispatch a rapid response team to conduct a shoe-leather epidemiology investigation to characterize cases, identify exposures, and collect samples.
✓
C.
Restrict movement into and out of the village without further investigation.
✓
D.
Wait for the cluster to resolve on its own.
✓
A.
Issue a general health warning about kidney disease.
✓
B.
Conduct a rapid field investigation to identify common exposures, geographical distribution, and patient characteristics.
✓
C.
Wait for more cases to appear.
✓
D.
Assume it's a genetic predisposition.
✓
D.
Phase IV (Post-marketing surveillance).
✓
B.
They cannot establish individual-level associations due to the ecological fallacy.
✓
C.
They are always biased.
✓
D.
They only measure incidence.
✓
